The Employers Action Coalition on Healthcare and the Institute for Clinical and Economic Review, part of the Massachusetts General Hospital’s Institute for Technology Assessment, are launching a new website designed to give patients recently diagnosed with low-risk prostate cancer objective information about treatment choices.
EACH and ICER Launch Prostate Cancer Decision Aid Website
Boston-area provider groups participate in effort to give patients information on comparative effectiveness of management options for prostate cancer
The Employers Action Coalition on Healthcare (EACH), a group of employers, providers and health plans in Massachusetts, in conjunction with the Institute for Clinical and Economic Review (ICER), part of the Massachusetts General Hospital’s Institute for Technology Assessment, are launching a new website for patients recently diagnosed with low-risk prostate cancer. Based on the results of a comprehensive comparative effectiveness assessment of the management options for this disease conducted by ICER, the website was created with input from a national expert group and from expert clinicians from Boston Medical Center, Brigham and Women’s Hospital, Harvard Vanguard Medical Associates, Massachusetts General Hospital and Tufts Medical Center.
The website is designed to give patients and their families an objective source of information to help aid decision-making, so that they can have more informed discussions with their doctors about the choices for addressing their prostate cancer diagnosis.
Link to full EACH/ICER release.
Media Contacts: Sarah K. Emond, 617-724-5497, firstname.lastname@example.org
U.S. News & World Report ranks Mass General #2 in the nation and #1 in New England based on our quality of care, patient safety and reputation in 16 clinical specialties.
Search the archive for previously published news articles, press releases and publications.
Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.